Carcinoid Link

Introducing a New Program About Carcinoid Cancer

As you know, Novartis is dedicated to educating people about carcinoid cancer and to advancing the treatment of this debilitating disease. That's why we're proud to announce the launch of a new complimentary program called Carcinoid Link. As important partners with us in the fight against this disease, we want you to be among the first to have the opportunity to take advantage of Carcinoid Link—a comprehensive resource created to provide disease education, treatment information, and practical tips for those living with metastatic carcinoid cancer.

Exclusive Invitation Click here to enroll and get an article by an expert.

Be the First to Enroll in Carcinoid Link and Learn from an Expert

Together, we are committed to managing metastatic carcinoid cancer, today and into the future. That's why we hope you'll accept this invitation to enroll in Carcinoid Link. By doing so, you'll receive an important article by carcinoid specialist, Larry Kvols, M.D. This article provides background on the disease, as well as useful information about the importance of monitoring biochemical secretions for effective symptom management. To receive this educational article, just visit www.CarcinoidLink.com now and complete the simple online registration form. Once you submit this online form, your customized article will immediately appear on your screen.

In addition to this article, once you enroll in the Carcinoid Link program you'll also receive customized E-mails—as well as access to other resources including webcasts—to help you stay informed about carcinoid cancer. Some of the topics that will be covered in the materials you will receive include:

  • The importance of monitoring biochemical secretions
  • How to partner with doctors and other healthcare team members to manage the condition
  • Helpful, practical ways to cope with the disease so it has less impact on daily life

Partners Together: Our Mutual Commitment to Carcinoid Cancer Care

We know that you are actively working to manage metastatic carcinoid cancer, and that's why we hope you'll take advantage of this exclusive opportunity to be among the first to join Carcinoid Link. Your involvement in learning more about the disease makes a real difference. Once you have access to this new resource, including the article by Larry Kvols, M.D., you'll be doing even more on your path toward effective management of metastatic carcinoid cancer.

Do you know someone who may benefit from this program? Click here to send them an invitation to enroll.

Novartis Pharmaceuticals Corporation
East Hanover, New Jersey 07936
© 2007 Novartis. All rights reserved. | Privacy Policy
This program is a service of Novartis and is intended for U.S. residents only.

SDS-900186-A